Cargando…

Wnt5a expression and prognosis in stage II–III colon cancer

Cancer metastases accounts for most cancer deaths. The secreting glycoprotein Wnt5a impairs tumor cell migration and reduces invasiveness and metastasis. High Wnt5a expression in tumor cells is correlated to better outcomes in patients with breast, prostate and epithelial ovarian cancer. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lund, Cecilia Margareta, Dyhl-Polk, Anne, Nielsen, Dorte Lisbeth, Riis, Lene Buhl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553443/ https://www.ncbi.nlm.nih.gov/pubmed/33045677 http://dx.doi.org/10.1016/j.tranon.2020.100892

Ejemplares similares

Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
por: Dyhl-Polk, Anne, et al.
Publicado: (2021)

Novel Model to Predict the Prognosis of Patients with Stage II–III Colon Cancer
por: Xu, Yansong, et al.
Publicado: (2020)

Specific CDK4/6 inhibition in breast cancer: a systematic review of current clinical evidence
por: Polk, Anne, et al.
Publicado: (2017)

Immunoscore(®) as a predictor of response to chemotherapy in stage II and stage III colon cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2015)

Association of collagen deep learning classifier with prognosis and chemotherapy benefits in stage II‐III colon cancer
por: Jiang, Wei, et al.
Publicado: (2023)

Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods
por: Zhang, Chunze, et al.
Publicado: (2022)

Pre- and Perioperative Inflammatory Biomarkers in Older Patients Resected for Localized Colorectal Cancer: Associations with Complications and Prognosis
por: Dolin, Troels Gammeltoft, et al.
Publicado: (2021)

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
por: van den Broek, Evert, et al.
Publicado: (2016)

The Prognosis and Recurrence Pattern of Right- and Left-Sided Colon Cancer in Stage II, Stage III, and Liver Metastasis After Curative Resection
por: Nakamura, Yasuyuki, et al.
Publicado: (2021)

Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2016)

Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer
por: Shanmugam, Chandrakumar, et al.
Publicado: (2011)

Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
por: Viñal, David, et al.
Publicado: (2022)

Inhibitors targeting CDK4/6, PARP and PI3K in breast cancer: a review
por: Nur Husna, Siti Muhamad, et al.
Publicado: (2018)

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2018)

A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
por: Polk, Anne, et al.
Publicado: (2014)

The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)
por: Lund, Cecilia Margareta, et al.
Publicado: (2021)

Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer
por: Jee, Sun Hee, et al.
Publicado: (2011)

Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer
por: Polk, Anne, et al.
Publicado: (2016)

EPSTI1 as an immune biomarker predicts the prognosis of patients with stage III colon cancer
por: Wang, Xitao, et al.
Publicado: (2022)

Predictors of recurrence free survival for patients with stage II and III colon cancer
por: Tsikitis, Vassiliki L, et al.
Publicado: (2014)

Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
por: de Wit, Meike, et al.
Publicado: (2012)

Prognostic impact of mutation profiling in patients with stage II and III colon cancer
por: Shen, Yinchen, et al.
Publicado: (2016)

Prognostic significance of primary tumor localization in stage II and III colon cancer
por: Sakin, Abdullah, et al.
Publicado: (2018)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

The establishment of a hub differential gene model to predict prognosis in stage II and III right- and left-sided colon cancer patients
por: Zhou, You-Tao, et al.
Publicado: (2021)

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III
por: Taal, B G, et al.
Publicado: (2001)

MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer
por: James, Jaslin P., et al.
Publicado: (2020)

Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer
por: Zhou, Rui, et al.
Publicado: (2018)

The downregulation of NCXs is positively correlated with the prognosis of stage II–IV colon cancer
por: Xia, Zhixiu, et al.
Publicado: (2021)

Is prognosis uniformly excellent in patients with stage II MSI-high colon cancer?
por: Wang, Jane, et al.
Publicado: (2022)

Involvement in Chemotherapy Decision Making among Patients with Stage II and III Colon Cancer
por: Austin, Jessica D., et al.
Publicado: (2023)

Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa
por: Tan, Sarah Xinhui, et al.
Publicado: (2023)

Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings
por: Tashiro, Jo, et al.
Publicado: (2014)

Is a Microsatellite Instability Still Useful for Tailored Treatment in Stage II and III Colon Cancer?
por: Kim, Nam Kyu
Publicado: (2014)

Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer
por: Batra, Atul, et al.
Publicado: (2020)

A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
por: Ju, Huai‐Qiang, et al.
Publicado: (2019)

Erratum to “Involvement in Chemotherapy Decision Making among Patients with Stage II and III Colon Cancer”
Publicado: (2023)

Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2022)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer
por: Sarasqueta, C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_15kmn4kb43196lnflu0lpcm8pg